Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national blog main
amgen
boston blog main
chronic migraine
indiana
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
type 1 diabetes
adaptive biotechnologies
alector
allergan
alprazolam
apollomics
bernie sanders
beta bionics
bill & melinda gates foundation trust
black diamond therapeutics
boehringer ingelheim
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
calcitonin gene-related peptide
cancer
cancer drugs
cgrp inhibitors
civica rx
colucid pharmaceuticals
deals
detroit blog main
What
eli
4
×
approval
drug
fda
lilly
diabetes
giant
migraine
new
pharmaceutical
won
acute
addresses
announced
appetite
approved
bid
bio
black
boehringer
bread
butter
buyout
cancer
cash
causes
class
condition
decades
decision
developed
diamond’s
drugs
expand
fallen
friday
giving
grabbed
hasn’t
headache
Language
unset
Current search:
eli
×
biotech
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
